MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $671,509 | -35.1% | 204,106 | -18.9% | 0.00% | -50.0% |
| Q1 2023 | $1,034,882 | +104.4% | 251,796 | +191.5% | 0.00% | +33.3% |
| Q4 2022 | $506,222 | +36.1% | 86,386 | +56.8% | 0.00% | +50.0% |
| Q3 2022 | $372,000 | +247.7% | 55,089 | +138.2% | 0.00% | +100.0% |
| Q2 2022 | $107,000 | -91.0% | 23,126 | -92.3% | 0.00% | -90.0% |
| Q1 2022 | $1,195,000 | +232.9% | 299,454 | +418.5% | 0.01% | +233.3% |
| Q4 2021 | $359,000 | -57.8% | 57,757 | -7.9% | 0.00% | -70.0% |
| Q2 2021 | $851,000 | – | 62,685 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |